Cardiff Oncology CRDF Stock and A Breakdown of SPAC For Life Sciences: Clinical Researchers Explain

Q&A Session With Travis Mickle, "The People's CEO" on KMPH Stock and Upcoming Events

Inhibikase Therapeutics $ikt CEO Discusses Parkinson's Opportunities and Potential Of The Company!

First Wave BioPharma CEO Gives Company Updates On Acquisition and Pipeline - $fwbi Stock!

Travis Mickle, CEO KemPharm Answers ALL Viewer Questions On $kmph Company and the Future!

AQST Deep Dive and KMPH How Do They Interlink - What Is Hot?

Lineage Cell Therapeutics $LCTX Stock CEO Reveals Updates and Progress On the Amazon of Cell Therapy

RedHill Biopharma Stock $RDHL- Covid Catalyst Coming Up!

Epigenetics: The Next CRSPR type breakthrough? SLRX Stock Analysis!

$ARDX Ardelyx, Inc. In Depth Analysis Pre-PDUFA and Beyond

$cubt Repurposed Metformin: Curative Biotechnology, Inc. Might Be The Next Penny Stock To Blow Up!

$BCRX Marco Overview and Discussion: BioCryst A Midcap That Could Pop For Rare Disease

CEO Of Kintara Therapeutics $ktra Discusses His Career Path and Meeting A Massive Unmet Medical Need

Oncologist Convinced To Buy $GOVX and Hold Long Term. Small Cap With HUGE Potential in Vaccines!

Head Of Operations For $ktra Kintara Therapeutics Discussing Benefits Of Agile Study Glioblastoma

Brian Culley, CEO of Lineage Cell Therapeutics $LCTX Joins Us To Discuss Top Line Results For AMD

Corcept Therapeutics Incorporated (CORT) Stock Analysis: Hyperfocused and Poised For Growth!

$SQZ Stock SQZ Biotechnologies Company Analysis: Clinical Researchers Discuss!

5 Critical Upcoming FDA Decisions To Watch!

Looking at $blue BlueBird Bio and $ktra Kintara Therapeutics Stocks: Clinical Researchers Discuss

Looking at upcoming PDUFA for $fgen, $knsa, $pcrx, and bonus look at $onph biotech stocks

United Therapeutics UTHR Stock and A Mini CAR T Lesson

CRSP ONTX AQST Stocks: We Briefly Look Over These Biotech Opportunities

KMPH Stock Potential ADHD Approval To Soar! Clinical Researchers Examine!

Cardiff Oncology CRDF Stock and A Breakdown of SPAC For Life Sciences: Clinical Researchers Explain